iRadimed (IRMD)

• Market cap: $670M
• 1 day: -2.40%
• 5 days: 4.82%
• 1 month: -0.13%
• 3 months: -13.10%
• 6 months: -1.00%
• Year to date: -4.61%
• 1 year: 29.06%
• 5 years: 140.85%
• 10 years: 223.52%
• Sector: Healthcare
• Industry: Medical Devices

About: iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Employees: 160

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

209% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 11

69% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 39

14% more funds holding

Funds holding: 143 [Q3] → 163 (+20) [Q4]

12% more capital invested

Capital invested by funds: $339M [Q3] → $381M (+$42.3M) [Q4]

1.46% more ownership

Funds ownership: 53.24% [Q3] → 54.7% (+1.46%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

81% less call options, than puts

Call options by funds: $33K | Put options by funds: $176K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $72 37% upside
• Avg. target: $72 37% upside
• High target: $72 37% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Roth MKM Jason Wittes 35% 1-year accuracy 7 / 20 met price target

37% upside $72

Buy Reiterated

14 Feb 2025